Boyibang, a Welldoc-like diabetes management app and platform, secured 4.5 million yuan ($733,974) of angel investment from Ameba Capital and Wu Jiong, executive director of Guahao (report in Chinese).

Founded in 2012, Boyibang combines self-monitoring, online consultation and smart +people reminding services. The app helps patients to keep track of their blood sugar level, food intake, sports and medication on the app, which will generate a real-time medical record. Based on these data, doctors will provide custom health management plans for patients.

The user apps of Boyibang is consisted of four parts, namely records, reminder, IM and knowledge database, where patients can browse articles on the illness or read posts recommended by doctors.

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

What you get

Full access to all premium content and our full archives

Members'-only newsletters

Preferential access and discounts to all TechNode events

Direct access to the TechNode newsroom

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

Emma Lee

Emma Lee is Shanghai-based tech writer, covering startups and tech happenings in China and Asia in general. We are looking for stories related to tech and China. Reach her at lixin@technode.com.